TRML
Price
$18.59
Change
-$0.89 (-4.57%)
Updated
Jan 14, 04:16 PM (EDT)
Capitalization
499.26M
VYGR
Price
$5.06
Change
-$0.22 (-4.17%)
Updated
Jan 14, 04:18 PM (EDT)
Capitalization
288.42M
56 days until earnings call
Ad is loading...

TRML vs VYGR

Header iconTRML vs VYGR Comparison
Open Charts TRML vs VYGRBanner chart's image
Tourmaline Bio
Price$18.59
Change-$0.89 (-4.57%)
Volume$201
Capitalization499.26M
Voyager Therapeutics
Price$5.06
Change-$0.22 (-4.17%)
Volume$145
Capitalization288.42M
TRML vs VYGR Comparison Chart
Loading...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRML vs. VYGR commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRML is a Hold and VYGR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (TRML: $19.47 vs. VYGR: $5.28)
Brand notoriety: TRML and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRML: 142% vs. VYGR: 77%
Market capitalization -- TRML: $499.26M vs. VYGR: $288.42M
TRML [@Biotechnology] is valued at $499.26M. VYGR’s [@Biotechnology] market capitalization is $288.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRML’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • TRML’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than TRML.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRML’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • TRML’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than TRML.

Price Growth

TRML (@Biotechnology) experienced а -10.44% price change this week, while VYGR (@Biotechnology) price change was -12.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.05%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was -2.91%.

Reported Earning Dates

TRML is expected to report earnings on Mar 15, 2024.

VYGR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-7.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($499M) has a higher market cap than VYGR($288M). TRML YTD gains are higher at: -3.994 vs. VYGR (-6.878). VYGR has higher annual earnings (EBITDA): 14.1M vs. TRML (-78.78M). VYGR has more cash in the bank: 345M vs. TRML (282M). TRML has less debt than VYGR: TRML (290K) vs VYGR (45.3M). VYGR has higher revenues than TRML: VYGR (164M) vs TRML (0).
TRMLVYGRTRML / VYGR
Capitalization499M288M173%
EBITDA-78.78M14.1M-559%
Gain YTD-3.994-6.87858%
P/E RatioN/A8.00-
Revenue0164M-
Total Cash282M345M82%
Total Debt290K45.3M1%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRMLVYGR
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
81%
Bullish Trend 7 days ago
78%
Momentum
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
85%
MACD
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 7 days ago
88%
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERSTX25.280.22
+0.88%
Eaton Vance Large-Cap Value R
IVGIX22.190.18
+0.82%
VY® Invesco Growth and Income I
BSDAX13.65N/A
N/A
BlackRock SMID-Cap Growth Equity Inv A
MSEPX19.64N/A
N/A
Morgan Stanley Inst Emerging Mkts C
LEGAX70.32-0.38
-0.54%
Columbia Large Cap Growth A

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-1.17%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
38%
Loosely correlated
-5.28%
SLRN - TRML
36%
Loosely correlated
+4.37%
KYMR - TRML
35%
Loosely correlated
-2.49%
VYGR - TRML
35%
Loosely correlated
-3.12%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with PLRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-3.12%
PLRX - VYGR
45%
Loosely correlated
-2.00%
RGNX - VYGR
44%
Loosely correlated
-7.46%
XENE - VYGR
41%
Loosely correlated
-0.42%
ARWR - VYGR
39%
Loosely correlated
+2.27%
AURA - VYGR
39%
Loosely correlated
-1.32%
More